Literature DB >> 19234181

IL-21 mediates suppressive effects via its induction of IL-10.

Rosanne Spolski1, Hyoung-Pyo Kim, Wei Zhu, David E Levy, Warren J Leonard.   

Abstract

IL-21 is a pleiotropic cytokine that is required for normal Ig production. We previously showed that IL-21 was elevated in BXSB-Yaa mice with systemic lupus erythematosus. These mice also had elevated IL-10 levels, and we now show that IL-21 induces IL-10 mRNA and protein, suggesting unexpected immunosuppressive activities for IL-21. Indeed, Th1 priming with IL-21 leads to accumulation of cells with immunosuppressive activity, and IL-21 overexpression decreases specific Ab production after immunization in an IL-10-dependent fashion. Moreover, we show that IL-21 signaling is required for maximal induction of IL-10 by IL-6 or IL-27. Overall, our data indicate that IL-21 regulates immune responses at least in part by inducing IL-10 and reveal unanticipated immunosuppressive actions for this cytokine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234181      PMCID: PMC2756221          DOI: 10.4049/jimmunol.0802978

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Cytokines and immunodeficiency diseases.

Authors:  W J Leonard
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

2.  STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.

Authors:  M L McLemore; S Grewal; F Liu; A Archambault; J Poursine-Laurent; J Haug; D C Link
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.

Authors:  H Asao; C Okuyama; S Kumaki; N Ishii; S Tsuchiya; D Foster; K Sugamura
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain.

Authors:  K Ozaki; K Kikly; D Michalovich; P R Young; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  IL-10 regulates murine lupus.

Authors:  Zhinan Yin; Gul Bahtiyar; Na Zhang; Lanzhen Liu; Ping Zhu; Marie E Robert; Jennifer McNiff; Michael P Madaio; Joe Craft
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

8.  The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3.

Authors:  Tania Habib; Shantha Senadheera; Kenneth Weinberg; Kenneth Kaushansky
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

9.  STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation.

Authors:  Chien-kuo Lee; Regina Raz; Ramon Gimeno; Rachel Gertner; Birte Wistinghausen; Kenichi Takeshita; Ronald A DePinho; David E Levy
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

10.  Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells.

Authors:  Andrea L Wurster; Vikki L Rodgers; Abhay R Satoskar; Matthew J Whitters; Deborah A Young; Mary Collins; Michael J Grusby
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

View more
  80 in total

1.  Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.

Authors:  Girdhari Lal; Yumi Nakayama; Apoorva Sethi; Amit K Singh; Bryna E Burrell; Neeraja Kulkarni; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Jonathan S Bromberg
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

2.  Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Authors:  Lindsay L Jones; Rajshekhar Alli; Bofeng Li; Terrence L Geiger
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

Review 3.  Galectin-1 research in T cell immunity: past, present and future.

Authors:  Filiberto Cedeno-Laurent; Charles J Dimitroff
Journal:  Clin Immunol       Date:  2011-10-06       Impact factor: 3.969

4.  IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.

Authors:  Nasim Akhtar Ansari; Rajiv Kumar; Shalini Gautam; Susanne Nylén; Om Prakash Singh; Shyam Sundar; David Sacks
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

5.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

Review 6.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

7.  sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Authors:  Massimo Ghio; Paola Contini; Maurizio Setti; Gianluca Ubezio; Clemente Mazzei; Gino Tripodi
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

8.  Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Authors:  Alan M Hanash; Lucy W Kappel; Nury L Yim; Rebecca A Nejat; Gabrielle L Goldberg; Odette M Smith; Uttam K Rao; Lindsay Dykstra; Il-Kang Na; Amanda M Holland; Jarrod A Dudakov; Chen Liu; George F Murphy; Warren J Leonard; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

Review 9.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

10.  The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.

Authors:  Lionel Apetoh; Francisco J Quintana; Caroline Pot; Nicole Joller; Sheng Xiao; Deepak Kumar; Evan J Burns; David H Sherr; Howard L Weiner; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2010-08-01       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.